Dr. Ala Moshiri, MD, PhD

Dr. Moshiri practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Moshiri's NPI, 1063619674, was assigned on June 27, 2007. Dr. Moshiri graduated from University Of Washington School Of Medicine in 2006. Dr. Moshiri's California license number on file is C55401.

Dr. Moshiri's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Moshiri's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Moshiri to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moshiri practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Moshiri's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Moshiri is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Moshiri's licenses on file in 2 states: California and Maryland.

Dmand AI lists age-related macular degeneration, cataract, glaucoma, hypertensive retinopathy, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion and surgical retina and vitreous procedures among the conditions Dr. Moshiri treats.

CMS data shows 2,466 Medicare services from Dr. Moshiri across 12 procedure codes in 2024, for 452 Medicare patients. Medicare paid $99,398 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 452 Medicare patients who saw Dr. Moshiri in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moshiri's median patient age at 70, with 55% women.

In 2024, Dr. Moshiri wrote 96 Medicare Part D claims for 36 patients. 89% of them were for generic drugs. CMS names the drug for 56 of them, across 2 drugs with 11 or more claims each, at $609 in total drug cost. In 2023, CMS named 34 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Moshiri for performance year 2024, reported as part of a group. Dr. Moshiri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 82 papers to Dr. Moshiri, published from 2015 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Tomography, Optical Coherence, Retina and Disease Models, Animal. Dr. Moshiri has published most often in Invest Ophthalmol Vis Sci. Dr. Moshiri's most frequent co-authors are Glenn C. Yiu, MD, PhD, Susanna S. Park, MD, PhD and Elad Moisseiev, MD.

Dmand AI links Dr. Moshiri to 2 clinical trials. Conditions studied include Retinitis Pigmentosa and Retinal Dystrophies.

CMS Open Payments shows 63 general payments to Dr. Moshiri from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $8,734.

Dmand AI lists 1 award for Dr. Moshiri, most recently CMS Stage 1 EHR in 2013.

Dr. Moshiri graduated from University Of Washington School Of Medicine in 2006.

Dr. Moshiri is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.